Kymera Therapeutics, Inc.
KYMR
Pozycja w akcjach
#2179
Kymera Therapeutics, Inc. is a biopharmaceutical company dedicated to... Kymera Therapeutics, Inc. is a biopharmaceutical company dedicated to discovering and developing pioneering small molecule therapeutics. These treatments operate by harnessing the body's inherent protein degradation system to selectively eliminate disease-causing proteins. The company's pipeline features several programs, including the IRAK4 program, currently in Phase I clinical trials, which targets various immunology-inflammation disorders such as hidradenitis suppurativa, atopic dermatitis, macrophage activation syndrome, generalized pustular psoriasis, and rheumatoid arthritis. Additionally, Kymera is advancing its IRAKIMiD program, designed to address MYD88-mutated diffuse large B cell lymphoma. Other key programs include the STAT3 program, focused on hematological malignancies, solid tumors, autoimmune diseases, and fibrosis, as well as the MDM2 program, which is also aimed at hematological malignancies and solid tumors. The company was founded in 2015 and maintains its headquarters in Watertown, Massachusetts.
Cena akcji
$114.06
Kapitalizacja rynkowa
$9.38B
Zmiana (1 dzień)
5.54%
Zmiana (1 rok)
88.52%
Kraj
US
Handel Kymera Therapeutics, Inc. (KYMR)
Kategoria
Healthcare
Liczba akcji w obrocie dla Kymera Therapeutics, Inc. (KYMR)
Liczba akcji w obrocie na dzień June 2026: 98.18M
Zgodnie z najnowszymi raportami finansowymi i ceną akcji Kymera Therapeutics, Inc., aktualna liczba akcji w obrocie to 98.18M. Na koniec December 2023 firma posiadała 58.37M akcji w obrocie. Liczba akcji w obrocie jest zwykle kształtowana przez podziały akcji i skupy akcji.
Historia liczby akcji w obrocie dla Kymera Therapeutics, Inc. (KYMR) od 2018 do 2026
Akcje w obrocie na koniec każdego roku
| Rok | Akcje w obrocie | Zmień |
|---|---|---|
| 2026 (TTM) | 98.18M | 30.83% |
| 2024 | 75.04M | 28.58% |
| 2023 | 58.37M | 8.22% |
| 2022 | 53.93M | 12.39% |
| 2021 | 47.99M | 7.70% |
| 2020 | 44.56M | 0.06% |
| 2019 | 44.53M | 0.00% |
| 2018 | 44.53M | 0.00% |
Akcje w obrocie dla podobnych firm lub konkurentów
| Firma | Akcje w obrocie | Różnica | Kraj |
|---|---|---|---|
| 253.90M | 158.61% |
US
|
|
| 396.00M | 303.35% |
US
|
|
| 478.91M | 387.80% |
AU
|
|
| - | - |
CH
|
|
| 62.19M | -36.66% |
NL
|
